These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31170120)

  • 21. Prucalopride for the treatment of constipation: a view from 2015 and beyond.
    Bassotti G; Usai Satta P; Bellini M
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New pharmacological treatment options for chronic constipation.
    Corsetti M; Tack J
    Expert Opin Pharmacother; 2014 May; 15(7):927-41. PubMed ID: 24661106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
    Gale JD
    Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prucalopride is no more effective than placebo for children with functional constipation.
    Mugie SM; Korczowski B; Bodi P; Green A; Kerstens R; Ausma J; Ruth M; Levine A; Benninga MA
    Gastroenterology; 2014 Dec; 147(6):1285-95.e1. PubMed ID: 25239590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What role for prucalopride in constipation?
    Drug Ther Bull; 2011 Aug; 49(8):93-6. PubMed ID: 21831905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating constipation with prucalopride: one size does not fit all.
    Nurko S; Saps M
    Gastroenterology; 2014 Dec; 147(6):1214-6. PubMed ID: 25457845
    [No Abstract]   [Full Text] [Related]  

  • 27. Prucalopride. In chronic constipation: poorly documented risks.
    Prescrire Int; 2011 May; 20(116):117-20. PubMed ID: 21648173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel therapies for constipation.
    Thayalasekeran S; Ali H; Tsai HH
    World J Gastroenterol; 2013 Dec; 19(45):8247-51. PubMed ID: 24363515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Table: Safety of drugs for IBS in pregnancy and lactation (online only).
    Med Lett Drugs Ther; 2020 Mar; 62(1594):e48-e49. PubMed ID: 32324174
    [No Abstract]   [Full Text] [Related]  

  • 30. [Some practical questions on chronic stipsis treatment with prucalopride].
    Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurological and psychiatric adverse events with prucalopride: case report and possible mechanisms.
    Carnovale C; Pellegrino P; Perrone V; Antoniazzi S; Pozzi M; Nisic A; Clementi E; Radice S
    J Clin Pharm Ther; 2013 Dec; 38(6):524-5. PubMed ID: 23889005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.
    Luthra P; Camilleri M; Burr NE; Quigley EMM; Black CJ; Ford AC
    Lancet Gastroenterol Hepatol; 2019 Nov; 4(11):831-844. PubMed ID: 31474542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A real-world study of persistence and adherence to prescription medications in patients with chronic idiopathic constipation in the United States.
    Cash BD; Lu M; Lembo A; Feuerstadt P; Nguyen L; Terasawa E; Ayyagari R; Du S; Pi S; Westermeyer B; Terreri B; Boules M; Moshiree B
    J Manag Care Spec Pharm; 2024 Oct; 30(10):1136-1148. PubMed ID: 39321115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
    Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
    Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: a systematic review and network meta-analysis.
    Nelson AD; Camilleri M; Chirapongsathorn S; Vijayvargiya P; Valentin N; Shin A; Erwin PJ; Wang Z; Murad MH
    Gut; 2017 Sep; 66(9):1611-1622. PubMed ID: 27287486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacotherapy in Patients with Chronic Constipation].
    Kim SJ; Park KS
    Korean J Gastroenterol; 2017 Aug; 70(2):64-71. PubMed ID: 28830131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC; Suares NC
    Gut; 2011 Feb; 60(2):209-18. PubMed ID: 21205879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prucalopride for chronic constipation.
    Lacy BE; Loew B; Crowell MD
    Drugs Today (Barc); 2009 Dec; 45(12):843-53. PubMed ID: 20135019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular Safety of Prucalopride in Patients with Chronic Constipation: A Multinational Population-Based Cohort Study.
    Gilsenan A; Fortuny J; Cainzos-Achirica M; Cantero OF; Flynn RWV; Garcia-Rodriguez L; Harding A; Kollhorst B; Karlsson P; Linnér L; MacDonald TM; Odsbu I; Plana E; Ruigómez A; Schink T; Ziemiecki R; Andrews EB
    Drug Saf; 2019 Oct; 42(10):1179-1190. PubMed ID: 31134512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prucalopride on symptoms of chronic constipation.
    Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
    Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.